Girshick Birgit has filed 52 insider transactions across 1 company since March 2021.
Most recent transaction: a gift of 328 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. ($CRL) on March 04, 2026.
Activity breakdown: 2 open-market purchases and 10 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | G | Common Stock | 328 | $0.00 | 72,055.0000 | 49,217,000 | 0.45% | 0.00% |
| Jan. 30, 2026 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | A | Common Stock | 9500 | $0.00 | 75,444.0000 | 49,217,000 | 14.41% | 0.02% |
| Jan. 30, 2026 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 3061 | $211.68 | 72,383.0000 | 49,217,000 | 4.06% | 0.01% |
| May 30, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | A | Common Stock | 12239 | $135.63 | 66,227.0000 | 51,201,000 | 22.67% | 0.02% |
| May 31, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 283 | $135.63 | 65,944.0000 | 51,201,000 | 0.43% | 0.00% |
| May 26, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 281 | $136.73 | 54,347.0000 | 51,201,000 | 0.51% | 0.00% |
| May 27, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 242 | $136.73 | 54,105.0000 | 51,201,000 | 0.45% | 0.00% |
| May 28, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 117 | $138.65 | 53,988.0000 | 51,201,000 | 0.22% | 0.00% |
| Feb. 25, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | G | Common Stock | 430 | $0.00 | 54,628.0000 | 51,141,000 | 0.78% | 0.00% |
| Feb. 20, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | P | Common Stock | 1514 | $164.63 | 55,058.0000 | 51,141,000 | 2.83% | 0.00% |
| Jan. 31, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | A | Common Stock | 4057 | $0.00 | 54,569.0000 | 51,141,000 | 8.03% | 0.01% |
| Jan. 31, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 1025 | $165.57 | 53,544.0000 | 51,141,000 | 1.88% | 0.00% |
| May 31, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | A | Common Stock | 3838 | $0.00 | 50,512.0000 | 51,552,000 | 8.22% | 0.01% |
| May 31, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | A | Stock Options (Right to Buy) | 8722 | $208.44 | 8,722.0000 | 51,552,000 | 9999.99% | 0.02% |
| May 29, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 216 | $214.51 | 46,674.0000 | 51,552,000 | 0.46% | 0.00% |
| May 26, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 376 | $217.21 | 47,264.0000 | 51,552,000 | 0.79% | 0.00% |
| May 27, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 242 | $217.21 | 47,022.0000 | 51,552,000 | 0.51% | 0.00% |
| May 28, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 132 | $217.21 | 46,890.0000 | 51,552,000 | 0.28% | 0.00% |
| Jan. 29, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 1135 | $220.28 | 48,064.0000 | 51,338,000 | 2.31% | 0.00% |
| Jan. 29, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | A | Common Stock | 3451 | $0.00 | 49,199.0000 | 51,338,000 | 7.54% | 0.01% |
| Feb. 15, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | G | Common Stock | 424 | $0.00 | 47,691.0000 | 51,338,000 | 0.88% | 0.00% |
| Jan. 10, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | M | Stock Options (Right to Buy) | 5916 | $0.00 | 0.0000 | 51,338,000 | 100.00% | 0.01% |
| Jan. 29, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | A | Common Stock | 3526 | $0.00 | 49,274.0000 | 51,338,000 | 7.71% | 0.01% |
| Jan. 29, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 1159 | $220.28 | 48,115.0000 | 51,338,000 | 2.35% | 0.00% |
| Jan. 10, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | M | Common Stock | 5916 | $144.67 | 50,365.0000 | 51,338,000 | 13.31% | 0.01% |
| Jan. 10, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 4617 | $213.14 | 45,748.0000 | 51,338,000 | 9.17% | 0.01% |
| Jan. 10, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | M | Common Stock | 5916 | $215.19 | 50,365.0000 | 51,338,000 | 13.31% | 0.01% |
| Jan. 10, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | M | Stock Options (Right to Buy) | 5916 | $0.00 | 0.0000 | 51,338,000 | 100.00% | 0.01% |
| Jan. 10, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 4590 | $215.19 | 45,775.0000 | 51,338,000 | 9.11% | 0.01% |
| Nov. 20, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | P | Common Stock | 1322 | $187.82 | 44,449.0000 | 50,944,000 | 3.07% | 0.00% |
| March 1, 2021 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | G | Common Stock | 350 | $0.00 | 28,710.0000 | 0 | 1.20% | 0.00% |
| May 28, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 132 | $194.12 | 43,693.0000 | 50,944,000 | 0.30% | 0.00% |
| May 29, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 216 | $194.12 | 43,477.0000 | 50,944,000 | 0.49% | 0.00% |
| May 26, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | A | Stock Options (Right to Buy) | 9145 | $194.12 | 9,145.0000 | 50,944,000 | 9999.99% | 0.02% |
| May 26, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | A | Common Stock | 3812 | $0.00 | 44,067.0000 | 50,944,000 | 9.47% | 0.01% |
| May 27, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 242 | $194.12 | 43,825.0000 | 50,944,000 | 0.55% | 0.00% |
| March 7, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | G | Common Stock | 475 | $0.00 | 40,255.0000 | 50,944,000 | 1.17% | 0.00% |
| Feb. 22, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 308 | $243.60 | 40,730.0000 | 50,944,000 | 0.75% | 0.00% |
| Feb. 16, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | S | Common Stock | 502 | $256.48 | 41,038.0000 | 50,944,000 | 1.21% | 0.00% |
| Feb. 16, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | M | Stock Options (Right to Buy) | 3205 | $0.00 | 0.0000 | 50,944,000 | 100.00% | 0.01% |
| Feb. 16, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | S | Common Stock | 157 | $252.87 | 43,568.0000 | 50,944,000 | 0.36% | 0.00% |
| Feb. 16, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | S | Common Stock | 84 | $246.13 | 44,159.0000 | 50,944,000 | 0.19% | 0.00% |
| Feb. 16, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | M | Common Stock | 3205 | $109.34 | 44,243.0000 | 50,944,000 | 7.81% | 0.01% |
| Feb. 16, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | S | Common Stock | 417 | $254.55 | 42,932.0000 | 50,944,000 | 0.96% | 0.00% |
| Feb. 16, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | S | Common Stock | 219 | $253.78 | 43,349.0000 | 50,944,000 | 0.50% | 0.00% |
| Feb. 16, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | S | Common Stock | 1392 | $255.65 | 41,540.0000 | 50,944,000 | 3.24% | 0.00% |
| Feb. 16, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | S | Common Stock | 183 | $251.56 | 43,725.0000 | 50,944,000 | 0.42% | 0.00% |
| Feb. 16, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | S | Common Stock | 78 | $250.69 | 43,908.0000 | 50,944,000 | 0.18% | 0.00% |
| Feb. 16, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | S | Common Stock | 73 | $249.22 | 43,986.0000 | 50,944,000 | 0.17% | 0.00% |
| Feb. 16, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | S | Common Stock | 100 | $248.07 | 44,059.0000 | 50,944,000 | 0.23% | 0.00% |
| Jan. 27, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | F | Common Stock | 3153 | $244.29 | 41,038.0000 | 50,944,000 | 7.13% | 0.01% |
| Jan. 27, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Girshick Birgit | Corporate Executive VP & COO | A | Common Stock | 8435 | $0.00 | 44,191.0000 | 50,944,000 | 23.59% | 0.02% |